This finding is in keeping with results in mice showing that hepatocyte-specific expression of β-catenin in mice via hydrodynamic tail vein injection (Tao et al., 2016) or under control of the albumin promoter (Nejak-Bowen et al., 2010) is not sufficient for HCC initiation. The gene discussed is ALB; the disease is hepatocellular carcinoma.